Tcg Crossover Management, LLC Tango Therapeutics, Inc. Transaction History
Tcg Crossover Management, LLC
- $415 Million
- Q1 2025
A detailed history of Tcg Crossover Management, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 10,736,000 shares of TNGX stock, worth $37.7 Million. This represents 3.54% of its overall portfolio holdings.
Number of Shares
10,736,000
Previous 10,736,000
-0.0%
Holding current value
$37.7 Million
Previous $33.2 Million
55.66%
% of portfolio
3.54%
Previous 5.42%
Shares
3 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
98MCall Options Held
1.1KPut Options Held
0-
Trv Gp Iv, LLC Boston, MA16.9MShares$59.2 Million88.92% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$37.3 Million1.14% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$19.4 Million1.76% of portfolio
-
Nextech Invest Ag5.53MShares$19.4 Million3.19% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.61MShares$16.2 Million0.04% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $309M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...